These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Brain-reactive autoantibodies are nearly ubiquitous in human sera and may be linked to pathology in the context of blood-brain barrier breakdown. Levin EC; Acharya NK; Han M; Zavareh SB; Sedeyn JC; Venkataraman V; Nagele RG Brain Res; 2010 Jul; 1345():221-32. PubMed ID: 20546711 [TBL] [Abstract][Full Text] [Related]
8. Galanin and α-MSH autoantibodies in cerebrospinal fluid of patients with Alzheimer's disease. Costa A; Bini P; Hamze-Sinno M; Moglia A; Franciotta D; Sinforiani E; Ravaglia S; Bole-Feysot C; Hökfelt T; Déchelotte P; Fetissov SO J Neuroimmunol; 2011 Dec; 240-241():114-20. PubMed ID: 22078238 [TBL] [Abstract][Full Text] [Related]
10. Distribution of glutamate receptor subunit NMDAR1 in the hippocampus of normal elderly and patients with Alzheimer's disease. Ikonomovic MD; Mizukami K; Warde D; Sheffield R; Hamilton R; Wenthold RJ; Armstrong DM Exp Neurol; 1999 Nov; 160(1):194-204. PubMed ID: 10630204 [TBL] [Abstract][Full Text] [Related]
11. Neuronal RNA in relation to Alz-50 immunoreactivity in Alzheimer's disease. Doebler JA; Markesbery WR; Anthony A; Davies P; Scheff SW; Rhoads RE Ann Neurol; 1988 Jan; 23(1):20-4. PubMed ID: 2449843 [TBL] [Abstract][Full Text] [Related]
12. Immunoreactivity of calcium binding protein secretagogin in the human hippocampus is restricted to pyramidal neurons. Attems J; Quass M; Gartner W; Nabokikh A; Wagner L; Steurer S; Arbes S; Lintner F; Jellinger K Exp Gerontol; 2007 Mar; 42(3):215-22. PubMed ID: 17116382 [TBL] [Abstract][Full Text] [Related]
13. Dysfunction of the blood-cerebrospinal fluid-barrier and N-methyl-D-aspartate glutamate receptor antibodies in dementias. Busse M; Kunschmann R; Dobrowolny H; Hoffmann J; Bogerts B; Steiner J; Frodl T; Busse S Eur Arch Psychiatry Clin Neurosci; 2018 Aug; 268(5):483-492. PubMed ID: 28176002 [TBL] [Abstract][Full Text] [Related]
14. Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer's disease. Kountouras J; Boziki M; Gavalas E; Zavos C; Deretzi G; Grigoriadis N; Tsolaki M; Chatzopoulos D; Katsinelos P; Tzilves D; Zabouri A; Michailidou I Int J Neurosci; 2009; 119(6):765-77. PubMed ID: 19326283 [TBL] [Abstract][Full Text] [Related]
15. Antibodies in the cerebrospinal fluid of some Alzheimer's disease patients recognize amoeboid microglial cells in the developing rat central nervous system. McRae A; Ling EA; Polinsky R; Gottfries CG; Dahlström A Neuroscience; 1991; 41(2-3):739-52. PubMed ID: 1870709 [TBL] [Abstract][Full Text] [Related]
16. Basal expression and induction of glutamate decarboxylase and GABA in excitatory granule cells of the rat and monkey hippocampal dentate gyrus. Sloviter RS; Dichter MA; Rachinsky TL; Dean E; Goodman JH; Sollas AL; Martin DL J Comp Neurol; 1996 Sep; 373(4):593-618. PubMed ID: 8889946 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease. Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308 [TBL] [Abstract][Full Text] [Related]
18. Association between naturally occurring anti-amyloid β autoantibodies and medial temporal lobe atrophy in Alzheimer's disease. Kimura A; Takemura M; Saito K; Yoshikura N; Hayashi Y; Inuzuka T J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):126-131. PubMed ID: 27330118 [TBL] [Abstract][Full Text] [Related]